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Abstract
Background: Stress management interventions may prove useful in preventing the detrimental effects of stress on health.
This study assessed the effects of a stress management intervention on the psychophysiological response to stress in
patients with rheumatoid arthritis (RA).
Methods: Seventy-four patients with RA, who were randomly assigned to either a control group or a group that received
short-term stress management training, performed a standardized psychosocial stress task (Trier Social Stress Test; TSST) 1
week after the stress management training and at a 9-week follow-up. Psychological and physical functioning, and the
acute psychophysiological response to the stress test were assessed.
Results: Patients in the intervention group showed significantly lower psychological distress levels of anxiety after the
training than did the controls. While there were no between-group differences in stress-induced tension levels, and
autonomic (a-amylase) or endocrine (cortisol) responses to the stress test 1 week after the intervention, levels of stress-
induced tension and cortisol were significantly lower in the intervention group at the 9-week follow-up. Overall, the
response to the intervention was particularly evident in a subgroup of patients with a psychological risk profile.
Conclusion: A relatively short stress management intervention can improve psychological functioning and influences the
psychophysiological response to stress in patients with RA, particularly those psychologically at risk. These findings might
help understand how stress can affect health and the role of individual differences in stress responsiveness.
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Introduction
The aetiology of rheumatoid arthritis (RA), a chronic inflamma-
tory systemic disease that affects 1% of the general population [1,2],
remains poorly understood. Despite the growing spectrum of
pharmacological therapies aimed at reducing disease activity [3],
many patients continue to suffer from pain, fatigue, functional
disability, and an overall poor quality of life [4]. One of the factors
believed to play a role in the initiation, maintenance, and
exacerbation of RA is psychological stress [5,6]. Evidence is
accumulating that stress-evoked physiological changes, brought
about by activation of the two main branches of the stress response
system, the autonomic nervous system (ANS) and the hypothalamus-
pituitary-adrenal (HPA) axis, might have detrimental effects on
disease activity and health [7–10]. This has led to growing interest
into the effects of stress management interventions on physiological
outcomes. Stress-reducing psychological interventions aimed at
modifying stress appraisal and decreasing subjective anxiety might
alter autonomic arousal (e.g., decrease heart rate and galvanic
responses, and increase tonic vasodilation) and influence neuroen-
docrine activity (e.g., lower cortisol levels) [11–14]. Alleviating the
physiological response to a stressor could be particularly relevant in
clinical populations, specifically in patients with immune-mediated
diseases, such as RA. Although evidence is limited, there are
indications that stress management interventions might affect basal
autonomic or endocrine parameters, such as norepinephrine levels,
urinaryfreecortisoloutput,serumdehydroepiandrosterone sulphate,
or testosterone levels in patients with HIV and cancer [15–21].
Psychological interventions, such as multimodal cognitive-
behavioral therapy (CBT), biofeedback, stress management
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improvements in psychological and physical functioning in
patients with RA, with similar effects for the different types of
interventions [4,22–25]. Only incidental effects have been found
on biological measures of disease, such as C-reactive protein (CRP)
and erythrocyte sedimentation rate (ESR) [26–28]. Medical and
methodological explanations have been searched for this lack of
uniform effects of psychological interventions on biological
measures, such as disease status, medication regimen, and used
time frame to assess physiological stress measures. However, there
is also relatively consistent support that inter-individual variation
in psychological risk factors also play a role [29,30]. Specifically,
previous research increasingly indicates the importance of
evaluating psychological risk factors when investigating treatment
outcome, such as the experience of interpersonal stress and levels
of depression [29,31]. For instance, there is increasing evidence
that patients at risk, for example those who report being sensitive
to stress or who have heightened levels of distress (e.g., heightened
anxiety and depression), are especially prone to the detrimental
effects of stress on disease activity and accompanying physical
symptoms [32,33]. Moreover, stress-induced changes in physio-
logical function are particularly observed in these groups of
patients psychologically at risk [29,31,34]. Although there is
preliminary evidence that stress management interventions can
influence the acute psychophysiological response to stress in
healthy individuals [35,36], it is not known whether such
interventions alter the acute-phase psychophysiological response
to a stressful event in immune-comprised patients with chronic
inflammatory diseases, such as RA.
In this study, we examined the effects of a short-term individual
stress management intervention on the self-reported, sympathetic,
and neuroendocrine response to a validated psychosocial stress test
(Trier Social Stress Task, TSST) in patients with RA and in a
subsample of patients at risk of heightened anxiety and depression.
We hypothesized that patients in the intervention group,
particularly those at risk, would show reduced levels of distress
and a diminished psychophysiological response to acute psycho-
social stress compared with controls both after the intervention
and at the 9-week follow-up after prolonged use of the stress
management techniques.
Materials and Methods
Ethics statement
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1. The study protocol was approved by the regional
medical ethics committee (CMO Regio Arnhem-Nijmegen) and
registered in The Netherlands National Trial Register (NTR 1193).
Written informed consent was obtained from all participants.
Participants
Patients with RA were recruited from the Department of
Rheumatology at the Radboud University Nijmegen Medical
Centre and the St Maartenskliniek in Nijmegen, the Netherlands.
Inclusion criteria were a diagnosis of RA according to the American
Rheumatism Association 1987 classification criteria [37] and a
minimum age of 18. Exclusion criteria were severe physical
comorbidity (e.g., major cardiac problems, psoriasis, malignancies,
severe respiratory or renal insufficiency, hepatitis B, HIV, and
insulin-dependent diabetes mellitus); severe psychiatric disturbances
that might interfere with the study protocol; pregnancy; illiteracy;
use of antidepressants, anxiolytics, or antipsychotics; and psycho-
logical treatment.
Procedure
Ninety-six eligible patients were enrolled (see Figure 1) and
randomized through simple randomization with an equal
allocation ratio to one of two parallel groups, the control or the
treatment condition, in accordance with the fixed therapist’s time
schedule and using a computerized random generator scheme
made by an independent researcher. Allocation was concealed for
the participant enroller until the moment that participants were
scheduled into the treatment program. After randomization, 19
participants (n=8 intervention, n=11 control) withdrew from the
study prematurely (prior to the first stress test), because of physical
comorbidity (n=3 intervention, n=6 control), severe illness or
death of a significant other (n=3 intervention, n=1 control), a
change in pharmacotherapy (n=1 control), or lack of motivation
(n=2 intervention, n=3 control). In addition, 3 participants (n=1
intervention, n=2 control) reported taking antidepressants or
anxiolytics after randomization and were excluded based on our
predefined exclusion criteria. Seven of 74 participants withdrew
from the second stress test (n=4 intervention, n=3 control)
because of physical comorbidity (n=2 intervention), death of a
significant other (n=1 intervention), and lack of motivation (n=1
intervention, n=3 control). There were no differences in socio-
demographic variables (sex, age, education level) and psycholog-
ical and physical functioning at baseline (anxiety, negative mood,
positive mood, Disease Activity Score 28 (DAS28)) between the
drop-outs and the completers.
Participants were post hoc divided into 2 subgroups based on
the participant’s risk status by means of a median split on a
composite score of baseline anxiety and negative mood assessed
with the IRGL (see Measures) [30,32].
Study design. At the first assessment, the medical history and
current disease activity of all participants were evaluated at the
University Medical Centre, and in the subsequent two weeks half
of the participants started the individual stress management
training program. All participants performed a stress test three
weeks after the first assessment (i.e., second assessment) and 9
weeks thereafter (i.e., third assessment). Stress test sessions were
run between 13.00 and 15.30 hours. Participants were asked to
refrain from using caffeine, alcohol, nicotine, or physical exercise
on the test day, and from eating 2 hours before the first blood
sample was drawn. Forty minutes before the stress test, a venous
catheter was inserted into the non-dominant arm (immunological
data presented elsewhere) and participants were asked to rest for
20 minutes. They then performed the stress test. During periods of
rest, participants looked at a natural history documentary.
Psychophysiological parameters (tension, saliva, and blood) were
measured at baseline (i.e., after 20 minutes of rest), immediately
after the stress test, and 10, 20, 40, and 60 minutes after cessation
of the test.
Stress task. The Trier Social Stress Test (TSST) is a
standardized laboratory stress task that consists of a mock job
interview and mental arithmetic in front of an audience. The
persons conducting the TSST were unaware of group allocation of
the participants. The TSST lasts 15 minutes, including
introduction to the job interview and a 5-minute preparation
phase, and has repeatedly been found to induce self-reported,
neuroendocrine, and autonomic nervous system responses [38].
Stress management training. Participants in the
intervention group received individual stress management
training with a focus on psycho-education and the principles of
applied relaxation, including progressive, cue controlled, and
differential relaxation [30,39–42]. In addition, patients were
taught breathing and visualization exercises. Participants
attended 4 individual 1-hour sessions with a trained therapist
Psychophysiological Stress Response in RA
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relaxation exercises and, at the end of each session, a training
manual containing a summary of the information and stress-
reducing techniques introduced in that session. As consolidating
homework, participants assessed stress-relevant situations and
behaviours in their daily life and used relaxation exercises for
1 hour at least twice a day during the 2 weeks of the stress
management intervention. Subsequently, patients were
encouraged to continue the homework assignments, to use the
relaxation exercises, to focus on long-term goals, and to stick to a
relapse-prevention checklist during the 2-month follow-up period.
Measures
Demographic, clinical, and self-report measures at
baseline, post-treatment, and follow-up. Demographic
variables were assessed with a general checklist for age, sex,
marital status, education, and medical history. Educational level
was measured using seven categories that can be classified as
primary, secondary, and tertiary education, representing on
average 7, 12, and 17 years of education, respectively.
Physical functioning was assessed in terms of disease activity.
Disease activity of patients was measured with the DAS28, which
is a validated composite score for swelling and tenderness of 28
joints, a Visual Analogue Scale (VAS) of the patients’ general
health, and the ESR (mm/h) [43].
Psychological functioning was measured with the state anxiety and
negative and positive mood scales of the IRGL [44,45]. The IRGL
is derived from the Arthritis Impact Measurement Scales (AIMS)
[46]. The 10-item anxiety scale is a shortened version of the Dutch
State Anxiety Scale [47,48] and assesses anxiety over the last 2
weeks (sample item: ‘‘I worry too much about unimportant
matters.’’); the 6-item negative mood scale assesses various
negative mood states over the previous 2 weeks (sample item:
‘‘How depressed were you during the past 2 weeks?’’); and the 6-
item positive mood scale assesses various positive mood states over
the previous 2 weeks (sample item: ‘‘How cheerful were you during
the past 2 weeks?’’).
Patients’evaluationof stress management training. After
trainingended,patientswereaskedtoindicatetheirsatisfactionwith
the training and its usefulness (score range 0–10, ranging from ‘‘not
at all’’ to ‘‘very’’), and to what extent their distress and tension had
improved (score range 1–4, ranging from ‘‘not’’ to ‘‘very’’).
Psychophysiological measures during the stress test at
post-treatment and follow-up. VAS tension. Participants rated
Figure 1. Flow chart showing participant selection and drop-out.
doi:10.1371/journal.pone.0027432.g001
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rest), during the stress test (retrospectively), and 10, 20, 40, and
60 minutes after cessation of the stress test.
Alpha-amylase as a measure of autonomic reactivity. Saliva
samples were collected with salivettes (Sarstedt, Rommelsdorf,
Germany) and stored at 235uC until further biochemical analyses.
After saliva samples were thawed, centrifuged, and diluted, a-
amylase (AA) was measured with the Aeroset (Abbott). According
to the procedure, a-amylase hydrolyses the reagent CNPG3 (2-
chloro-4-nitrophenyl-a-D-maltotrioside) to CPNP (2-chloro-4-
nitrophenol), CNPG2 (2-chloro-4-nitrophenyl-a-D-maltoside),
maltotriose, and glucose. The rate of CPNP formation was
detected spectrophotometrically at 404 nm to give a direct
measurement of amylase in saliva.
Cortisol as a measure of endocrine reactivity. Salivary cortisol
was measured with a commercial Luminescence Enzyme Immu-
noassay (IBL, Hamburg, Germany). After samples were thawed
and centrifuged, 20-ml aliquots of the supernatant were pipetted
into anti-cortisol (rabbit-) antibody-coated microtitre plate wells,
followed by 100 ml of enzyme conjugate (horseradish peroxydase).
After 3-hour incubation at room temperature, the plate was
washed and luminescence reagent (luminol/peroxide) was added
to each well, with subsequent reading of the signal in a
luminometer. At levels of 3.3 and 27.3 nmol/l, within-assay
coefficients of variation (CV) were 8.7 and 3.6% respectively, and
between-assay CVs were 12.3 and 7.7%. To reduce error variance
caused by between-run variation, all samples from one participant
were analyzed in the same run.
Statistics
Analyses were performed on the 74 participants completing the
study protocol. Skewed data (i.e., negative mood and all
physiological parameters) were logarithmically transformed to
render unskewed data distributions before statistical analysis.
Between-group differences in age, sex, education, and psycholog-
ical measures at baseline were tested with independent Student’s t–
tests and Chi-square analyses. For cortisol, the area under the
curve (AUCg) was calculated using the trapezoid formula [49].
Baseline differences in psychophysiological outcome parameters
(VAS tension, cortisol, and a-amylase) (t=0 minutes) and AUCg
in the intervention and control groups were evaluated with
analyses of covariance (ANCOVA). Effects of the stress manage-
ment training (i.e., psychological/physical functioning and psy-
chophysiological responses to the stress test) were evaluated using a
linear mixed model taking into account the specific design features
of the study. The primary outcome measure was state anxiety as a
measure of psychological distress. The effects on secondary
outcomes of psychological and physical functioning (positive and
negative mood, and DAS28) and psychophysiological stress
parameters (tension, cortisol, and a-amylase measured during
the stress test) at the post-treatment and follow-up assessments
were also assessed. In analyses of the effects of the stress
management training on psychological and physical functioning,
measures of psychological and physical functioning were used as
dependent variables, and group, baseline measurement of the
dependent variable (pretreatment), and time levels (post-treatment
and follow-up) were used as independent variables. With regard to
the psychophysiological response to the stress test, the three
psychophysiological outcome measures (tension, cortisol, and a-
amylase) were used as dependent variables, and group, baseline
measurement of the dependent variable (t=0 minutes), and time
levels (t=20; t=30; t=40; t=60; and t=80 minutes) were used
as independent variables. Explorative subgroup analyses were
performed to test whether effects were stronger or only held in
patients at risk as compared to patients not at risk (also see
Procedure) by incorporating risk group and risk group by
treatment interactions into the analysis models. A significant
interaction was interpreted as an indication of subgroup
differences with respect to the effect of the treatment. Stratified
analyses were performed to gain a better understanding of the
nature of the responses in the subgroups of patients.
For every outcome measure, an unstructured covariance matrix
was used to model the dependence between repeated measure-
ments of the dependent variable. Owing to a slightly unequal
distribution of sex across the two groups (p=0.08) and a trend
towards higher anxiety scores at baseline in the intervention group
(p=0.09) (see Results section, Patient characteristics), all analyses
were performed with the covariates sex and baseline (pretreat-
ment) anxiety. In addition, cortisol analyses were also performed
with the additional covariate hormonal contraceptives [36] (see
Results section, Patient characteristics).
A priori power calculation resulted in an optimal sample size of
N=64 (expected adjusted effect size of f=0.45 of the primary
outcome measure psychological distress (state anxiety), a power of
0.90, and a=0.05). However, because there were missing blood
samples (a venous catheter could not be inserted in n=15 patients
during one or two stress tests) and the high drop-out rate before
the start of the first stress test was high (n=22; see procedure), we
increased the earlier estimate of 64 patients to 96. In total, data of
the 74 patients included in the analyses were 95% complete
regarding psychological and physical outcomes at baseline, post-
treatment, and follow-up, and 97% complete regarding psycho-
physiological parameters at post-treatment and follow-up. Physi-
ological data for three participants at one of the assessment
moments (cortisol levels in two participants and amylase levels in
one participant) were excluded from analyses because levels were
four standard deviations higher than the mean for at least one of
the six time points during the stress test. All analyses were
performed using SPSS 16.0 for Windows. For all analyses, the
significance level was a=0.05 (two-sided). Unless indicated, all
results are means 6 standard deviation (SD).
Results
Patient characteristics
Baseline demographic and disease-related characteristics of the
74 participants are presented in Table 1. The two groups did not
differ significantly regarding age, education level, mean disease
activity, and mean disease duration. However, there tended to be
more women in the intervention group (x
2=3.155, p=0.08).
Thirty-three of 74 patients were taking biologicals (including
etanercept, adalimumab, abatacept, and infliximab), 54 patients
were taking DMARDS (including methotrexate (MTX), sulfasal-
azine, hydroxychloroquine, leflunomide, and/or azathioprine), 47
patients were taking NSAIDs, and 14 patients were taking
prednisone (,10 mg/day). Twenty-four patients received medi-
cation known to affect the ANS (including b-blockers, ACE-
inhibitors, Ca
2+-blockers, a1-blockers, thiazides (or –related), ACh-
receptor antagonists, b2-adrenergics, and anti-histamines), and 7
patients used hormonal contraceptives (6 intervention, 1 control;
x
2=3.120, p=0.08). There were no significant group differences
in the use of biologicals, DMARDs, steroids, and medication
known to influence the ANS, except for the use of NSAIDs, which
was significantly higher in the intervention group (x
2=7.349,
p=0.01). There were no significant group differences in
pretreatment measures of negative and positive mood, and disease
activity, but anxiety scores tended to be higher in the intervention
group than in the control group (t(67.835)=21.715, p=0.09)
Psychophysiological Stress Response in RA
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covariates sex and baseline anxiety, with the additional covariate
hormonal contraceptives for endocrine analyses.
Psychological and physical functioning
Satisfaction and usefulness of the training. Patients rated
their satisfaction with the intervention with a score of 8.16 SD 1.2
and its usefulness with a score of 7.66 SD 2.0. Approximately
87% of patients in the intervention group reported an
improvement in stress and tension after the training (little
improvement by 42%, moderate improvement by 32%, and
strong improvement by 13%).
Psychological functioning in intervention and control
condition. Means and estimated marginal means (EMM; i.e.,
means corrected for the covariates) (6 SEM) of the psychological
and physical outcomes are presented in Table 2. A significant
group effect was found for anxiety (F(1,69.887)=5.579, p=0.02);
the intervention group had a significantly lower anxiety score than
the control group after the intervention. Furthermore, patients in
the intervention group had significantly higher levels of positive
mood after the intervention than did patients in the control group
(group effect, F(1,67.436)=4.851, p=0.03). No overall group
effect was observed for negative mood (F(1,68.389)=0.028
p=0.87). Subgroup analyses showed a significant interaction
effect between condition (intervention/control) and risk group
(high/low) for anxiety (F(1,68.002)=7.820, p,0.01) and negative
mood (F(1,66.893)=11.509, p,0.01), but not for positive mood
(F(1,65.985)=0.205, p=0.65), indicating that high-risk patients
responded differently to the stress management training with
regard to anxiety and negative mood than did low-risk patients.
Table 1. Demographic characteristics, disease severity, and medical regimen of patients with rheumatoid arthritis in the
intervention and control groups*.
Intervention Control
(n=40) (n=34) p-value
No. females/males 27/13 16/18 .08
Age (years 6 SD) 57.2611.8 (range 24–75) 60.769.2 (range 26–80) .17
Education level (%) .56
Primary 7.5% 2.9%
Secondary 60.0% 70.6%
Tertiary 32.5% 26.5%
Disease Activity (DAS28) 2.661.0 (range 0.8–4.5) 2.661.1 (range 0.5–5.1) .81
Disease duration (years 6 SD) 15.7610.9 (range 5–51) 12.467.6 (range 3–37) .15
No. of patients currently under treatment for RA 38 32
Biologicals 17 16 .69
DMARDs 31 23 .43
NSAIDs 31 16 .007
Steroids (,10 mg/day) 9 5 .39
*Values are means 6 SD. RA=rheumatoid arthritis; DMARDs=disease-modifying anti-rheumatic drugs; NSAIDs=nonsteroidal anti-inflammatory drugs.
doi:10.1371/journal.pone.0027432.t001
Table 2. Means (6 SEM) and estimated marginal means (6 SEM) of psychological and physical outcomes of patients in the
intervention condition (IC: n=40) and the control condition (CC: n=34) pre- and post-treatment, and at follow-up.
Means (± SEM) Estimated marginal means (± SEM)
Pre-treatment Post-treatment Follow-up Post-treatment Follow-up
Psychological functioning
Anxiety IC 17.69 (0.94) 17.15 (0.76) 16.78 (0.74) 16.28 (0.36) 15.95 (0.39)*
CC 15.68 (0.70) 16.64 (0.79) 16.06 (0.72) 17.47 (0.39) 17.14 (0.42)
Negative IC 3.23 (0.66) 2.97 (0.53) 2.17 (0.46) 0.92 (0.06) 0.79 (0.08)
Mood CC 1.94 (0.40) 2.00 (0.51) 1.77 (0.43) 0.90 (0.07) 0.78 (0.08)
Positive IC 12.00 (0.68) 12.10 (0.64) 13.00 (0.53) 12.76 (0.48) 13.35 (0.40)*
Mood CC 12.97 (0.61) 12.18 (0.75) 12.48 (0.64) 11.55 (0.49) 12.14 (0.43)
Physical functioning
DAS28 IC 2.62 (0.16) 2.81 (0.16) 2.51 (0.20) 2.68 (0.09) 2.43 (0.10)
CC 2.56 (0.19) 2.56 (0.19) 2.48 (0.19) 2.68 (0.09) 2.43 (0.11)
*Significant between-group effect (p#0.05). Means of outcomes pre- and post-treatment, and at follow-up; and estimated marginal means of post-treatment and
follow-up, corrected for pretreatment measures (and other covariates).
doi:10.1371/journal.pone.0027432.t002
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scores (group effect, F(1,32.725)=8.128, p,0.01) and lower
negative mood scores (F(1,31.473)=4.021, p=0.05) were
present in the subgroup of high-risk patients in the intervention
group compared to high-risk controls, but not in low-risk patients
(group effect anxiety, F(1,33.898)=0.019, p=0.89; reverse group
effect negative mood, F(1,31.677)=8.644, p,0.01). In addition, a
trend towards higher positive mood scores was observed in high-
risk patients in the intervention group compared to controls
(F(1,31.578)=3.548, p=0.07), but not in low-risk patients
(F(1,31.256)=0.691, p=0.41).
Physical functioning in intervention and control
condition. There were no differences in disease activity (DAS28)
between control and intervention groups after the stress management
intervention (F(1,61.610)=0.004, p=0.95). Subgroup analyses
showed no interaction effect between condition (intervention/
control) and risk group (high/low) (F(1,59.864)=0.051, p=0.82).
Psychophysiological stress reactivity
Stress manipulation check. Both after treatment and at
follow-up, the stress test induced a significant increase in tension
(time effect, F(1,73)=304,899; p,0.001, and F(1,66)=182.031,
p,0.001, respectively; Figure 2), a-amylase (time effect,
F(1,69.211)=46.003; p,0.001, and F(1,65)=21.404, p,0.001,
respectively; Figure 3), and cortisol levels (time effect,
F(1,69.041)=29.566; p,0.001, and F(1,63.003)=9.688, p,0.01,
respectively; Figure 4) in all patients.
Baseline differences between intervention and control
condition. Both after treatment and at follow-up, there were no
significant differences between the intervention and control groups
in baseline levels (t=0 minutes) of tension (F=0.230, p=0.63 and
F=0.444, p=0.51, respectively), a-amylase (F=0.007, p=0.93
and F=0.326, p=0.57, respectively) and cortisol (F=1.530,
p=0.22 and F=1.729, p=0.19, respectively).
Post-treatmentpsychophysiologicalstressreactivity. After
treatment, levels of self-reported tension in response to the stress task
were similar in the intervention and control groups (group effect,
F(1,69.000)=0.340, p=0.56, Figure 2), as was autonomic reactivity
(group effect a-amylase, F(1,66.359)=0.068, p=0.80, Figure 3), and
endocrine reactivity (group effect cortisol, F(1,64.287)=0.315,
p=0.58, Figure 4; and AUCg: F(1,66)=0.734, p=0.40, Table 3),
indicating that patients in the intervention group did not have an
altered psychophysiological response to stress compared to patients in
the control group after the intervention. Subgroup analyses also
showed no interaction effect between condition (intervention/control)
and risk group (high/low) for psychophysiological measures of
Figure 2. Self-reported response to stress. Mean stress-induced VAS tension levels (6 SEM) in the intervention (IC) and control (CC) conditions
post-treatment (left; IC, n=40; CC, n=34) and at follow-up (right; IC, n=36; CC, n=31).
doi:10.1371/journal.pone.0027432.g002
Figure 3. Autonomic response to stress. Mean stress-induced a-amylase levels (6 SEM) of patients in the intervention (IC) and control (CC)
conditions at post-treatment (left; ICAA=9;CC AA=3) and at follow-up (right; ICAA=35; CCAA=31).
doi:10.1371/journal.pone.0027432.g003
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differently to the stress management training with regard to stress-
induced levels of tension, a-amylase, and cortisol.
Follow-up psychophysiological stress reactivity. At the
follow-up assessment, self-reported tension elicited by the stress test
was significantly lower in patients in the intervention group than in
patients in the control group (group effect, F(1,62.000)=6.092,
p=0.02, Figure 2). In addition, there was a significantly
diminished cortisol response (group effect, F(1,59.010)=4.877,
p=0.03, Figure 4) and a trend towards a lower total cortisol
output (AUCg) in the intervention group compared with the
control group (AUCg, F(1,60)=3.689, p=0.06, Table 3). The
autonomic response was similar in the two groups (group effect a-
amylase, F(1,61.085)=0.301, p=0.59, Figure 3). Subgroup
analyses showed no interaction effect between condition
(intervention/control) and risk group (high/low) for tension
(F(1,60.000)=1.919, p=0.17), but a trend towards an
interaction effect for a-amylase (F(1,58.996)=2.752, p=0.10)
and cortisol (F1,57.100)=3.682, p=0.06), indicating that high-
risk patients tended to respond differently to the stress
management training with regard to physiological measures of
stress than did low-risk patients. Inspection of the data by post-hoc
tests revealed that high-risk patients in the intervention group had
or tended to have lower overall levels of tension, a-amylase, and
cortisol than did high-risk patients in the control group (group
effect tension, F(1,28.000)=6.768, p=0.02; group effect a-
amylase, F(1,28.052)=3.495, p=0.07; group effect cortisol,
F(1,25.384)=7.450, p=0.01; and AUCg F(1,27)=5.264,
p=0.03); this was not the case for the low-risk patients (group
effect tension, F(1,29.000)=1.965, p=0.17; group effect a-
amylase, F(1,28.000)=1.277, p=0.27; group effect cortisol,
F(1,27.000)=0.818, p=0.37; and AUCg (F(1,28)=0.548,
p=0.47).
Discussion
This is the first study to assess psychological functioning and
psychophysiological responsiveness (subjective, autonomic, and
neuroendocrine) to a psychosocial stress task in patients with RA
who had received training in stress management. Results indicated
high satisfaction and perceived usefulness of the training, and a
lower anxiety and higher positive mood after the training in the
stress management than in the control group. No effect on disease
activity or post-treatment psychophysiological stress responsiveness
was found, but at follow-up (9 weeks after the training) the stress
management group showed a lower tension and cortisol response
to stress than the control group. These results were particularly
evident in a subgroup of patients psychologically at risk,
supporting previous findings of increased treatment effects in at-
risk patients [32,50]. Results of this study suggest that short-term
individual stress management training is not only able to improve
psychological functioning by the level of tension, but may also alter
psychophysiological responses to stress by reducing levels of
cortisol.
Stress might have detrimental effects on health, particularly in
clinical populations. Over the last decade, there has been an
increasing interest in the physiological effects of stress management
interventions for patient groups [15–21]. Studies of various forms
of stress management or cognitive-behavioral therapy in patients
with RA have only incidentally reported changes in overall disease
activity or biological indicators of disease after the intervention,
such as a decrease in overall disease activity [51,52], self-reported
disease flare-ups [24], and joint tenderness [53] in the intervention
group compared with the control group. Changes in cortisol values
[54], cytokine INF-c [54], C-reactive protein [28], and ESR [51]
have also been reported. In a response to the aforementioned
studies, the current study uniquely investigated the effects of a
stress management intervention on the acute-phase physiological
response to stress. It seems apparent that alterations on the
physiological level might particularly occur when interventions are
successful in changing the appraisal or perception of stressors [55].
We found that anxiety was significantly, but modestly, reduced
after 2 weeks of individual stress management training. After an
interval of 9 weeks, during which participants practiced the stress
management exercises at home, focusing on long-term stress
Figure 4. Endocrine response to stress. Mean stress-induced cortisol levels (6 SEM) in the intervention (IC) and control (CC) conditions post-
treatment (left; IC, n=39; CC, n=32) and at follow-up (right; IC, n=34; CC, n=31).
doi:10.1371/journal.pone.0027432.g004
Table 3. Area under the curve (AUCg) for cortisol (means 6
SEM) in the intervention (IC) and control (CC) conditions post-
treatment and at follow-up.
Post-treatment Follow-up
Intervention condition 42.59 (4.50) 33.46 (2.73)
Control condition 54.04 (7.30) 47.05 (6.96)
doi:10.1371/journal.pone.0027432.t003
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slightly lower and there was a lower stress-evoked cortisol response
in the intervention group compared with patients in the control
group. The effect of stress management training on psychophys-
iological stress responsiveness appears to be delayed, possibly
because repeated exercise during two months might have stronger
effects than exercise of two weeks; it takes time to integrate the
learned exercises into the daily lives of participants and to help
them cope with stress-provoking situations. Results are in line with
preliminary evidence suggesting that intervention-related physio-
logical changes, particularly those related to the immune system,
might become more pronounced with time [52,56].
To our knowledge, only two other studies assessed the acute-
phase physiological response to a laboratory stressor after stress
management [35,36]. Healthy males participating in a group-
based cognitive-behavioral stress management training showed a
significantly diminished cortisol response to the TSST 2 weeks
after the intervention [35], and this pattern, although less
pronounced, was also observed 4 months after a similar training
in male and female subjects [36]. Our results provide preliminary
evidence that, in line with recent findings in healthy populations,
stress management might also alter endocrine responsiveness to a
stress task in a clinically comprised population of patients with RA.
Our findings on endocrine responsiveness extend recent results
suggesting that basal cortisol levels and stress-induced cortisol
reactivity in patients with RA might not be significantly different
from those of healthy participants [8,57]. This implies that the
endocrine stress response system could be a target for stress
management interventions not only in healthy subjects, but also in
patients with immune-mediated diseases such as RA. These
interventions might prevent the possible negative physiological
consequences of stress on health. Although a reduced psycho-
physiological stress reaction was found at the follow-up in the stress
management group as compared to the control group, this was not
accompanied by a simultaneous decrease in disease activity.
Because the psychophysiological results were only found at the
longer term, this could imply that the effects on disease activity
may have occurred even later. Theoretically, a lowered cortisol
response might reflect a decreased psychological stress level and/
or an improvement in the functioning of all physiological
regulatory systems [e.g., 54]. However, no studies have yet
reliably shown the consequences of non-pharmacological cortisol
changes in rheumatoid arthritis and future studies with a longer-
term follow-up are needed to provide insight into this question.
In contrast to altered responses on self-reported tension and
cortisol, autonomic reactivity to stress was similar in the two
patient groups, as evidenced by the similar levels of a-amylase
levels in saliva, an indicator of sympathetic activity [58,59]. The
stress management intervention included principles and tech-
niques that are mainly aimed at reducing tension and negative
emotion by inducing a generalized relaxation response [60], which
is hypothesized to dampen sympathetic activity [61]. Several
studies investigating the effects of relaxation on autonomic changes
at baseline or in stress-provoking situations have reported reduced
galvanic and cardiovascular reactivity, but evidence of altered
autonomic responsiveness is not unequivocal [11–13,62–64]. Our
results suggest that the responses of the ANS and HPA axis to
(repeated) stress are not necessarily synchronous; a phenomenon
that has also been documented after recurrent exposure to the
same stressful stimulus, both in animal and human research [65].
Whereas (social-evaluative) threat and uncontrollability might be
the most important components contributing to an endocrine
response to a laboratory stressor [66], autonomic reactivity could
be an a-specific response to more generalized arousal, such as the
effort to do well [67,68]. As the cortisol response to a stressor is
sensitive to emotions and appraisals that are associated with
threats of the social self, such as rumination and submissiveness
[69], we hypothesize that the training specifically influenced the
endocrine response to stress due to changes in specific emotions.
Overall, subgroup analyses showed that the effects of the stress
management training on specific psychological outcomes and
physiological stress responses (anxiety and cortisol levels) were
particularly evident in a subgroup of patients at risk. Previous
studies have shown that particularly patients with RA with
heightened levels of anxiety and depression benefit from cognitive-
behavioral therapy, not only after treatment but also at follow-up
assessments [32]. The importance of subgroup analyses has also
been acknowledged in other patient populations [70–72]. The
lower anxiety and cortisol levels that were observed in the
intervention group at follow-up might be attributed to the
subgroup of high-risk patients. Additional subgroup effects were
found for negative mood and a-amylase levels at follow-up in the
subgroup of high-risk patients only. The latter findings support the
idea that beneficial effects of treatment might be particularly
observed in dysfunctional groups of patients and highlights the
importance of identifying subgroups of patients most likely to
benefit from a specific intervention in future studies of stress.
This study has several limitations. First, exclusion criteria with
regard to physical and psychological comorbidity may have
resulted in a homogenous sample of patients showing relatively
mild disease activity at baseline. In addition, the sample size was
relatively small for the subgroup analyses, particularly when
considering multiple testing. Therefore, the results of this study,
particularly those regarding subgroups of patients, should be
interpreted with caution and should be replicated in larger groups
of patients. Secondly, there were marginal baseline differences
between the intervention and control groups, with a trend towards
a higher female-to-male ratio in the intervention group and higher
anxiety scores. We statistically controlled for differences by adding
these confounders as a covariate in all analyses, in addition to the
use of oral contraceptives for endocrine analyses. It is well-
documented that not only has a person’s sex differential effects on
physiological stress response patterns [73,74], but also the
menstrual cycle, menopause, and the use of oral contraceptives
of females influence the cortisol response to laboratory stress
paradigms [75], which makes it difficult to control for these effects
in a heterogeneous group of patients with arthritis. Thirdly, due to
the character of the study, which included a no-treatment control
condition, it was impossible to blind patients and researchers for
the treatment status of the participants. However, by blinding the
persons conducting the Trier Social Stress Test for the treatment
status of participants, we tried to limit possible bias on the
psychophysiological stress response as much as possible. Lastly, we
decided against pre- and post-treatment assessment of psycho-
physiological stress reactivity, because repeated exposure to the
stress test has been found to elicit small habituation effects [76,77].
In addition, the small effects found on psychophysiological
measures at the follow-up assessment might have been larger if
the stress test would have been performed only once, at the follow-
up assessment.
This is the first study to provide preliminary evidence that a
relatively short stress management intervention not only improves
psychological functioning, but may also influence the psychophys-
iological response to stress (self-reported tension and cortisol
reactivity) in patients with RA, particularly those psychologically at
risk. Our study highlights the need to look at individual differences
in stress responsiveness and psychological factors that are able to
influence stress response patterns. Interventions such as the
Psychophysiological Stress Response in RA
PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e27432current stress management training, alone or as a part of a more
comprehensive treatment programme, may prove useful in
preventing the detrimental effects of stress on patients with
systemic inflammatory diseases, such as RA.
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